000 01579 a2200445 4500
005 20250513112454.0
264 0 _c19970327
008 199703s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/s0091-6749(97)70098-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAdelroth, E
245 0 0 _aProlonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cFeb 1997
300 _a210-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAnti-Asthmatic Agents
_xadministration & dosage
650 0 4 _aAsthma, Exercise-Induced
_xblood
650 0 4 _aBronchoconstriction
_xdrug effects
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aExercise Test
650 0 4 _aHumans
650 0 4 _aLeukotriene Antagonists
650 0 4 _aMale
650 0 4 _aMembrane Proteins
650 0 4 _aReceptors, Leukotriene
650 0 4 _aRespiratory Function Tests
650 0 4 _aThiazoles
_xadministration & dosage
650 0 4 _aTime Factors
700 1 _aInman, M D
700 1 _aSummers, E
700 1 _aPace, D
700 1 _aModi, M
700 1 _aO'Byrne, P M
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 99
_gno. 2
_gp. 210-5
856 4 0 _uhttps://doi.org/10.1016/s0091-6749(97)70098-8
_zAvailable from publisher's website
999 _c9030644
_d9030644